A loss of hormone receptor expression is one of the primary drivers of resistance to antihormonal therapy in breast cancer patients.[3d] An analysis of available TCGA data indicated that TRIM4 expression was closely related to luminal subtypes of breast cancer but not to TNBC (Figure3A,B). This evidence concerns the gene NR4A1 and breast carcinoma.